We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Qiagen says it recently expanded the QIAstat-Dx testing menu with a respiratory four-plex panel that differentiates between flu, RSV and COVID-19. Read More
Transit Scientific’s XO Cross devices are intended for guidewire support, exchange and contrast media injection in the peripheral vasculature, according to the Park City, Utah-based company. Read More
The software can be “customized to meet the needs of each lab’s users while maintaining the tight process controls needed for a regulated application,” the company said. Read More
LumiraDx said it has the manufacturing capacity to “enable rapid, high-sensitivity mass screening programs” in schools, events, travel and other settings. Read More
Guilford, Conn.-based Detect’s test is a molecular in vitro diagnostic test for the qualitative detection of nucleic acid from the coronavirus SARS-CoV-2, which causes COVID-19. Read More